Most of us have been tested for COVID-19 over the past few years. If that’s true of you, you know the routine: you go to a testing site, give your sample, a medical professional sends it to a laboratory, and you receive your results in a day or two. If this sounds familiar, you’ve benefited from PCR (Polymerase Chain Reaction) testing.
PCR is well known for its accuracy. It has limitations, however: it’s costly, time-consuming, and requires samples to be sent to central laboratories.
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Texas A&M Health and Burst IQ Partner to Optimize Clinical Genomics Research
What You Should Know:
-Texas A&M Health and BurstIQ, a leader in advanced data management, today announced a partnership to leverage LifeGraph®, a graph-powered, end-to-end data management platform, to transform clinical research.
-This collaboration aims to enhance patient and researcher interactions while ensuring the highest standards of patient privacy and data rights.
Texas A&M Health: Advancing Healthcare through Innovation and Research
Texas A&M Health is a
Read More
Olympics 2024 Anti-Doping: Why Innovation in Testing Is Key
As we approach the 2024 Summer Olympics, ensuring a clean game is a major priority for the International Olympic Committee. More than 1,000 people will be involved in various anti-doping testing stages, including chaperones, sample collection personnel, and dedicated anti-doping control spaces at each competition venue. The goal is to maintain fair competition so we can all trust that those Olympians who earn their podium moment did so without any artificial enhancement. Unfortunately, the
Read More
Genomics plc Expands Drug Discovery Collaboration with Vertex
What You Should Know:
-Genomics plc (Genomics), a healthcare company transforming health through the power of genomics today announced a three-year extension of the company’s collaboration with Vertex Pharmaceuticals Incorporated (Vertex) (Nasdaq: VRTX) to use human genetics and machine learning to improve the discovery and development of new precision medicines.
-The partnership, which began in 2018, was previously extended in 2021. The collaboration will now run until 2026.
Vertex and
Read More
Bluesight Diversion Trends Report Reveals $38M Lost to Drug Waste
What You Should Know:
- Bluesight, a provider of medication intelligence solutions, released its 2024 Diversion Trends Report, offering valuable insights for healthcare providers to improve controlled substance monitoring and patient safety.
- The report demonstrates progress in healthcare's fight against controlled substance diversion. However, the data also highlights areas for continued improvement, particularly in waste management and medication documentation.
The report
Read More
Cognizant and Yseop Partner to Deliver GenAI Medical Writing for Life Sciences
What You Should Know:
- Cognizant and Yseop, a leading AI software company, have joined forces to accelerate and streamline scientific content creation in the biopharmaceutical industry.
- The strategic partnership leverages Yseop Copilot, a generative AI tool, to transform medical writing, enhance productivity, and expedite the delivery of life-saving treatments.
Challenges of Traditional Medical Writing
The current process for creating scientific content is a
Read More
Uncapping Capacity: Solving for Technology Overload in Clinical Trials
The clinical trial landscape has greatly benefited from technological innovations over the past few decades. Innovation has expanded remote monitoring capabilities, patient recruitment tactics and the decentralization of clinical trials. However, one of the greatest hurdles that clinical researchers are currently facing is a deluge of disparate solutions across the clinical trial workflow. For example, surveys reveal that 60% of clinical research sites are using up to, and over, 20 systems on a
Read More
Verantos Launches Alzheimer’s Disease Pragmatic Registry to Support RWE Generation
What You Should Know:
- Verantos, the global leader in high-validity real-world evidence at scale, has launched its Alzheimer’s Disease Pragmatic Registry.
- This registry offers life sciences organizations rich and reliable data on patients with Alzheimer’s disease and related conditions.
Verantos: Leading High-Validity Real-World Evidence
Verantos is the global leader in high-validity real-world evidence at scale. By applying artificial intelligence to comprehensive patient
Read More
Tasso & InnoVero to Supply Anti-Doping Test to 2024 Paris Olympics, Expanded Partnership
What You Should Know:
- InnoVero, a global leader in providing innovative, athlete-centric collection technologies to anti-doping organizations worldwide and Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the extension of their partnership that was first initiated in 2021.
- In addition to collaboratively developing new athlete-centric solutions, InnoVero will continue to serve as the exclusive worldwide distributor of Tasso
Read More
Courier Health Raises $16.5M for First Patient CRM for Biopharma
What You Should Know:
- Courier Health, a technology company transforming patient experiences in the life sciences industry raises $16.5M in Series A funding led by Norwest Venture Partners with participation from existing investor Work-Bench.
- The investment fuels Courier Health's mission to provide biopharma companies with the tools to manage and personalize the patient journey for life-altering therapies.
Addressing the Rise of Specialty Medicines
The landscape of
Read More
